We present a clinical case of a 41-year-old male, with Hurley III HS flare.

Family history:
Mother diagnosed with HS Hurley I.

Personal history:
Diagnosed with HS since the age of 16. Smoker of 1 pack of cigarettes a day for more than 20 years. Non diabetic. Chronic auto inflammatory syndrome SAPHO/PAHS (Pyoderma gangrenosum/Acne Hidradenitis/Arthritis) in 2013. Haemophagocytic syndrome reactive to visceral Leishmaniasis in June 2018, due to immunosuppression by biological treatment. Fournier's gangrene in November 2018, which required debridement of the entire anterior abdominal wall and skin grafts. Hepatic cholestasis secondary to leishmaniasis. Cushing's syndrome and osteopenia secondary to low-dose corticotherapy for 10 years. Dilated cardiomyopathy secondary to cardiotoxicity in March 2019.

Treatments:
He has followed different systemic treatments: oral retinoids, antibiotics, corticosteroids, cyclosporine, infliximab, adalimumab; always with poor therapeutic response. Topical treatment with topical ATB, antiseptics, topical tracolimus.

Evolution:
In the last two years he has had several hospital admissions for new outbreaks, reactivation of Pyoderma gangrenosum lesions and superinfections by Pseudomona aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA).
She was readmitted in March due to worsening of the lesions in MMII.
